{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:37:27Z","timestamp":1792816647789,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Small Animal Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cvsm.2019.04.008","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T01:38:39Z","timestamp":1559785119000},"page":"837-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Anorexia and the Cancer Patient"],"prefix":"10.1016","volume":"49","author":[{"given":"Chad M.","family":"Johannes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret L.","family":"Musser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cvsm.2019.04.008_bib1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.2460\/javma.251.11.1260","article-title":"Recognizing, describing, and managing reduced food intake in dogs and cats","volume":"251","author":"Johnson","year":"2017","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"18","key":"10.1016\/j.cvsm.2019.04.008_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/vr.102751","article-title":"Investigating common clinical presentations in first opinion small animal consultations using direct observations","volume":"176","author":"Robinson","year":"2015","journal-title":"Vet Rec"},{"key":"10.1016\/j.cvsm.2019.04.008_bib4","series-title":"MIRATAZ\u00ae product detailer, US-MAZ-1800011","year":"2018"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib5","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.3390\/ani7030018","article-title":"Factors which influence owners when deciding to use chemotherapy in terminally ill pets","volume":"7","author":"Williams","year":"2017","journal-title":"Animals"},{"issue":"4","key":"10.1016\/j.cvsm.2019.04.008_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1098612X17710844","article-title":"Owners perception of their cat\u2019s quality of life when treated with a modified University of Wisconsin-Madison protocol for lymphoma","volume":"20","author":"Thornton","year":"2018","journal-title":"J\u00a0Feline Med Surg"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1476-5829.2010.00259.x","article-title":"Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy","volume":"9","author":"Malone","year":"2011","journal-title":"Vet Comp Oncol"},{"issue":"4","key":"10.1016\/j.cvsm.2019.04.008_bib8","first-page":"417","article-title":"Veterinary cooperative oncology group \u2013 common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats","volume":"14","year":"2011","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.cvsm.2019.04.008_bib9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1186\/1471-2407-14-828","article-title":"Emerging markers of cachexia predict survival in cancer patients","volume":"14","author":"Mondello","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cvsm.2019.04.008_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cvsm.2019.04.008_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1478271520093903002","article-title":"What is cancer anorexia-cachexia syndrome? A historical perspective","volume":"39","author":"Bennani-Baiti","year":"2009","journal-title":"J\u00a0R Coll Physicians Edinb"},{"key":"10.1016\/j.cvsm.2019.04.008_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fvets.2018.00205","article-title":"Evaluation of the prevalence and risk factors for undernutrition in hospitalized dogs","volume":"5","author":"Molina","year":"2018","journal-title":"Front Vet Sci"},{"issue":"6","key":"10.1016\/j.cvsm.2019.04.008_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/00480169.2017.1360161","article-title":"Preliminary description of aging cats and dogs presented to a New Zealand first-opinion veterinary clinic at end-of-life","volume":"65","author":"Gates","year":"2017","journal-title":"N\u00a0Z Vet J"},{"key":"10.1016\/j.cvsm.2019.04.008_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2460\/javma.252.4.440","article-title":"Intestinal lymphoma in dogs: 84 cases (1997-2012)","volume":"252","author":"Sogame","year":"2018","journal-title":"J\u00a0Am Vet Med Assoc"},{"key":"10.1016\/j.cvsm.2019.04.008_bib15","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/jvim.13965","article-title":"Association between body condition score and cancer prognosis in dogs with lymphoma and osteosarcoma","volume":"30","author":"Romano","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2019.04.008_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/vco.12086","article-title":"Criteria for designation of clinical substage in canine lymphoma: a survey of veterinary oncologists","volume":"14","author":"Barber","year":"2016","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.cvsm.2019.04.008_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2460\/ajvr.68.4.389","article-title":"Prevalence of obese dogs in a population of dogs with cancer","volume":"68","author":"Weeth","year":"2007","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2019.04.008_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1939-1676.2004.tb02607.x","article-title":"Evaluation of body condition and weight loss in dogs presented to a veterinary oncology service","volume":"18","author":"Michel","year":"2004","journal-title":"J\u00a0Vet Intern Med"},{"issue":"5","key":"10.1016\/j.cvsm.2019.04.008_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jfms.2007.02.005","article-title":"A\u00a0prospective investigation of the prevalence and prognostic significance of weight loss and changes in body condition in feline cancer patients","volume":"9","author":"Baez","year":"2007","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2019.04.008_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1939-1676.2011.00838.x","article-title":"Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats","volume":"26","author":"Freeman","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cvsm.2019.04.008_bib21","first-page":"255","article-title":"Quantitative assessment of muscle in dogs using a vertebral epaxial score","volume":"81","author":"Freeman","year":"2017","journal-title":"Can J Vet Res"},{"issue":"8","key":"10.1016\/j.cvsm.2019.04.008_bib24","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2460\/ajvr.2001.62.1234","article-title":"Metabolic alterations in dogs with osteosarcoma","volume":"62","author":"Mazzaferro","year":"2001","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cvsm.2019.04.008_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1939-1676.1990.tb00868.x","article-title":"Alterations in carbohydrate metabolism in canine lymphoma","volume":"4","author":"Vail","year":"1990","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2460\/ajvr.1997.58.03.277","article-title":"Alterations in carbohydrate metabolism in dogs with nonhematopoietic malignancies","volume":"58","author":"Ogilvie","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cvsm.2019.04.008_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.vetimm.2016.10.009","article-title":"Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs","volume":"182","author":"Calvalido","year":"2016","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.cvsm.2019.04.008_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/jvim.12090","article-title":"Chronic kidney disease in dogs in UK veterinary practices: prevalence, risk factors and survival","volume":"27","author":"O\u2019Neill","year":"2013","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2460\/javma.244.3.320","article-title":"Risk factors associated with the development of chronic kidney disease in cats evaluated at primary care veterinary hospitals","volume":"244","author":"Greene","year":"2014","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"12","key":"10.1016\/j.cvsm.2019.04.008_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1177\/1098612X14563097","article-title":"Survey of dietary and medication practices of owners of cats with chronic kidney disease","volume":"17","author":"Markovich","year":"2015","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2019.04.008_bib31","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/jvim.14561","article-title":"Evaluation of weight loss over time in cats with chronic kidney disease","volume":"30","author":"Freeman","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2019.04.008_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1939-1676.1998.tb02148.x","article-title":"Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure","volume":"12","author":"Freeman","year":"1998","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2019.04.008_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1748-5827.2004.tb00245.x","article-title":"Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002)","volume":"45","author":"Craven","year":"2004","journal-title":"J\u00a0Small Anim Pract"},{"issue":"Suppl 1","key":"10.1016\/j.cvsm.2019.04.008_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2885.2007.00867.x","article-title":"Efficacy and safety of dirlotapide in the management of obese dogs evaluated in two placebo-controlled, masked clinical studies in North America","volume":"30","author":"Wren","year":"2007","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cvsm.2019.04.008_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/vms3.83","article-title":"Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite","volume":"4","author":"Rhodes","year":"2017","journal-title":"Vet Med Sci"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib37","doi-asserted-by":"crossref","first-page":"E273","DOI":"10.3390\/ijms18020273","article-title":"From belly to brain: targeting the ghrelin receptor in appetite and food intake regulation","volume":"18","author":"Howick","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00012.2004","article-title":"Ghrelin: structure and function","volume":"85","author":"Kojima","year":"2005","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib39","doi-asserted-by":"crossref","first-page":"E297","DOI":"10.1152\/ajpendo.00582.2003","article-title":"Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues","volume":"287","author":"Cummings","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.cvsm.2019.04.008_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/eje.1.01818","article-title":"Influencing the between-feeding and edocrine responses of plasma ghrelin in healthy dogs","volume":"152","author":"Yokoyama","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.cvsm.2019.04.008_bib41","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2460\/ajvr.67.9.1557","article-title":"Effects of food intake and food withholding on plasma ghrelin concentrations in healthy dogs","volume":"67","author":"Bhatti","year":"2006","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.domaniend.2006.01.002","article-title":"Purification and characterization of feline ghrelin and its possible role","volume":"32","author":"Ida","year":"2007","journal-title":"Domest Anim Endocrinol"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/019262339802600203","article-title":"Effect of chronic growth hormone administration on skeletal muscle in dogs","volume":"26","author":"Molon-Noblot","year":"1998","journal-title":"Toxicol Pathol"},{"issue":"4","key":"10.1016\/j.cvsm.2019.04.008_bib44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA1 and ROMANA 2): results from two randomized, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.cvsm.2019.04.008_bib45","doi-asserted-by":"crossref","first-page":"E3471","DOI":"10.3390\/ijms19113471","article-title":"Efficacy of anamorelin, a novel non-peptide ghrelin analogue, in patients with advanced non-small cell lung cancer (NSCLC) and cachexia \u2013 review and expert opinion","volume":"19","author":"Currow","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cvsm.2019.04.008_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/drup.1998.0061","article-title":"The IGF\/IGF-1 receptor signaling pathway as a potential target for cancer therapy","volume":"2","author":"Burtscher","year":"1999","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.cvsm.2019.04.008_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2016.11.004","article-title":"The role of the IGF-1 Ec in myoskeletal system and osteosarcoma pathophysiology","volume":"108","author":"Armakolas","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jvp.12344","article-title":"Capromorelin increases food consumption, body weight, growth hormone, and sustained insulin-like growth factor 1 concentrations when administered to healthy adult beagle dogs","volume":"40","author":"Zollers","year":"2017","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.cvsm.2019.04.008_bib49","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/jvim.14607","article-title":"A\u00a0prospective, randomized, masked, placebo-controlled clinical study of capromorelin in dogs with reduced appetite","volume":"30","author":"Zollers","year":"2016","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cvsm.2019.04.008_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12917-016-0925-z","article-title":"Capromorelin oral solution (ENTYCE\u00ae) increases food consumption and body weight when administered for 4 consecutive days to healthy adult beagle dogs in a randomized, masked, placebo controlled study","volume":"13","author":"Zollers","year":"2017","journal-title":"BMC Vet Res"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jvp.12358","article-title":"Evaluation of the safety in dogs of long-term, daily oral administration of capromorelin, a novel drug for stimulation of appetite","volume":"40","author":"Zollers","year":"2017","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2019.04.008_bib52","series-title":"ENTYCE\u00ae (capromorelin oral solution) [package insert]","year":"2016"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jvp.12459","article-title":"Evaluation of the safety of daily administration of capromorelin in cats","volume":"41","author":"Wofford","year":"2018","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.cvsm.2019.04.008_bib54","article-title":"A\u00a0review of therapeutic uses of mirtazapine in psychiatric and medical conditions","volume":"15","author":"Alam","year":"2013","journal-title":"Prim Care Companion CNS Disord"},{"issue":"9","key":"10.1016\/j.cvsm.2019.04.008_bib55","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/1098612X14545273","article-title":"Pharmacological appetite stimulation: rational choices in the inappetent cat","volume":"16","author":"Agnew","year":"2014","journal-title":"J\u00a0Feline Med Surg"},{"issue":"10","key":"10.1016\/j.cvsm.2019.04.008_bib56","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.euroneuro.2016.08.012","article-title":"H1-histamine receptor affinity predicts weight gain with antidepressants","volume":"26","author":"Salvi","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib57","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v67n0313","article-title":"Effect of mirtazapine treatment on body composition and metabolism","volume":"67","author":"Laimer","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.cvsm.2019.04.008_bib58","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2885.2010.01244.x","article-title":"Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats","volume":"34","author":"Quimby","year":"2011","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2019.04.008_bib59","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1939-1676.2011.00780.x","article-title":"The pharmacokinetics of mirtazapine in cats with chronic kidney disease and in age-matched control cats","volume":"25","author":"Quimby","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib60","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.tvjl.2013.05.048","article-title":"Mirtazapine as an appetite stimulant and anti-emetic in cats with chronic kidney disease: a masked placebo-controlled crossover clinical trial","volume":"197","author":"Quimby","year":"2013","journal-title":"Vet J"},{"issue":"4","key":"10.1016\/j.cvsm.2019.04.008_bib61","first-page":"351","article-title":"Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects","volume":"16","author":"Kast","year":"2007","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib62","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tvjl.2011.05.010","article-title":"Pharmacokinetics of mirtazapine and its main metabolites in beagle dogs: a pilot study","volume":"192","author":"Giorgi","year":"2012","journal-title":"Vet J"},{"key":"10.1016\/j.cvsm.2019.04.008_bib64","series-title":"MIRATAZ\u00ae (mirtazapine transdermal ointment) [package insert]","year":"2018"},{"key":"10.1016\/j.cvsm.2019.04.008_bib65","article-title":"A\u00a0double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats with unintended weight loss","author":"Poole","year":"2018","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.cvsm.2019.04.008_bib66","series-title":"CERENIA\u00ae (maropitant citrate) tablets and injectable solution [package inset]","year":"2015"},{"issue":"8","key":"10.1016\/j.cvsm.2019.04.008_bib67","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/1098612X14555441","article-title":"Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial","volume":"17","author":"Quimby","year":"2015","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2019.04.008_bib68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/jsap.12237","article-title":"Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study","volume":"55","author":"Mason","year":"2014","journal-title":"J\u00a0Small Anim Pract"},{"key":"10.1016\/j.cvsm.2019.04.008_bib69","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1939-1676.2010.0611.x","article-title":"Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs","volume":"24","author":"Rau","year":"2010","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cvsm.2019.04.008_bib70","unstructured":"Clifford C, Bergman P, Trettien A, et\u00a0al. Evaluation of safety of maropitant citrate dosed orally at 2\u00a0mg\/kg once daily for 28 consecutive days in dogs with lymphoma. In: Veterinary Cancer Society Proceedings. Orlando, FL, USA, October 20\u201322, 2016."},{"issue":"1","key":"10.1016\/j.cvsm.2019.04.008_bib72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"10.1016\/j.cvsm.2019.04.008_bib73","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf"},{"issue":"6","key":"10.1016\/j.cvsm.2019.04.008_bib74","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cpt.108","article-title":"Cannabis in cancer care","volume":"97","author":"Abrams","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib75","first-page":"178","article-title":"Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs","volume":"82","author":"Bartner","year":"2018","journal-title":"Can J Vet Res"},{"key":"10.1016\/j.cvsm.2019.04.008_bib76","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rvsc.2018.12.003","article-title":"Pharmacokinetics of Bedrocan\u00ae, a cannabis oil extract, in fasting and fed dogs: an explorative study","volume":"123","author":"Lebkowska-Wieruszewska","year":"2018","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.cvsm.2019.04.008_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fvets.2018.00165","article-title":"Pharmacokinetics, safety, and clinical efficacy of cannabidiol treatment in osteoarthritic dogs","volume":"5","author":"Gamble","year":"2018","journal-title":"Front Vet Sci"},{"issue":"6","key":"10.1016\/j.cvsm.2019.04.008_bib79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.cvsm.2018.07.008","article-title":"Toxicology of marijuana, synthetic cannabinoids, and cannabidiol in dogs and cats","volume":"48","author":"Brutlag","year":"2018","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10.1016\/j.cvsm.2019.04.008_bib80","author":"US Food & Drug Administration"},{"key":"10.1016\/j.cvsm.2019.04.008_bib81","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/jsap.12526","article-title":"Owners\u2019 attitudes and practices regarding nutrition of dogs diagnosed with cancer presenting at a referral oncology service in Ontario, Canada","volume":"57","author":"Rajagopaul","year":"2016","journal-title":"J\u00a0Small Anim Pract"},{"key":"10.1016\/j.cvsm.2019.04.008_bib83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jfms.2009.09.013","article-title":"The inappetent hospitalized cat: clinical approach to maximizing nutritional support","volume":"11","author":"Chan","year":"2009","journal-title":"J\u00a0Feline Med Surg"},{"key":"10.1016\/j.cvsm.2019.04.008_bib84","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1939-1676.2008.0051.x","article-title":"A\u00a0phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors","volume":"22","author":"Grant","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cvsm.2019.04.008_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1476-5829.2011.00281.x","article-title":"Toxicity associated with epirubicin treatments in a large case series of dogs","volume":"10","author":"Marrington","year":"2012","journal-title":"Vet Comp Oncol"},{"key":"10.1016\/j.cvsm.2019.04.008_bib86","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1748-5827.2009.00891.x","article-title":"Owners\u2019 perception of carboplatin in conjunction with other palliative treatments for cancer","volume":"51","author":"Bowles","year":"2010","journal-title":"J\u00a0Small Anim Pract"},{"key":"10.1016\/j.cvsm.2019.04.008_bib87","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/jvim.14700","article-title":"Alternating rabacfosadine\/doxorubicin: efficacy and tolerability in na\u00efve canine multicentric lymphoma","volume":"31","author":"Thamm","year":"2017","journal-title":"J\u00a0Vet Intern Med"},{"issue":"11","key":"10.1016\/j.cvsm.2019.04.008_bib88","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1158\/1078-0432.CCR-08-1860","article-title":"Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision","volume":"15","author":"London","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cvsm.2019.04.008_bib89","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2460\/javma.231.10.1550","article-title":"Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004)","volume":"231","author":"Kim","year":"2007","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cvsm.2019.04.008_bib90","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1939-1676.2012.00897.x","article-title":"A\u00a0randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs","volume":"26","author":"Vail","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"issue":"10","key":"10.1016\/j.cvsm.2019.04.008_bib91","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1158\/1078-0432.CCR-08-3113","article-title":"Assessment of GS-9219 in a pet model of non-Hodgkin\u2019s lymphoma","volume":"15","author":"Vail","year":"2009","journal-title":"Clin Cancer Res"}],"container-title":["Veterinary Clinics of North America: Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561619300853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0195561619300853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:44:15Z","timestamp":1759283055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0195561619300853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0195561619300853"],"URL":"https:\/\/doi.org\/10.1016\/j.cvsm.2019.04.008","relation":{},"ISSN":["0195-5616"],"issn-type":[{"value":"0195-5616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anorexia and the Cancer Patient","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Small Animal Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cvsm.2019.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}